Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)—IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201

BACKGROUND: It is shown that the postoperative adjuvant chemotherapy for non-small cell lung cancer (NSCLC) was associated with survival benefit in an elderly population. We aimed to analyze the feasibility and efficacy of alternate-day S-1, an oral fluoropyrimidine, for adjuvant chemotherapy in eld...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Hiromasa, Soh, Junichi, Okumura, Norihito, Suzuki, Hiroyuki, Nakata, Masao, Fujiwara, Toshiya, Gemba, Kenichi, Sano, Isao, Fujinaga, Takuji, Kataoka, Masafumi, Terazaki, Yasuhiro, Fujimoto, Nobukazu, Kataoka, Kazuhiko, Kosaka, Shinji, Yamashita, Motohiro, Inokawa, Hidetoshi, Inoue, Masaaki, Nakamura, Hiroshige, Yamashita, Yoshinori, Hotta, Katsuyuki, Yoshioka, Hiroshige, Morita, Satoshi, Matsuo, Keitaro, Sakamoto, Junichi, Date, Hiroshi, Toyooka, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198543/
https://www.ncbi.nlm.nih.gov/pubmed/37205678
http://dx.doi.org/10.1371/journal.pone.0285273

Ejemplares similares

Ejemplares similares